Sabesan Yoganathan

Years Active: 2018-2021
Publications (10 Years): 5

St. John's University

University of Alberta (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

St. John's University

United States

Assistant Professor :: Pharmaceutical Sciences

Education History

University of Alberta

Canada

PHD :: Chemistry

Publications

Sabesan Yoganathan, Anushan Alagaratnam, Nikita Acharekar, Jing Kong
Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer. Cells 10 (2) (2021)
Xuwei Shao, Ahmed AbdelKhalek, Nader S Abutaleb, Uday Kiran Velagapudi, Sabesan Yoganathan, Mohamed N Seleem, Tanaji T Talele
Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors. Journal of medicinal chemistry 62 (21) (2019)
Tasneem Gandhi, Manali Patki, Jing Kong, Jagadish Koya, Sabesan Yoganathan, Sandra Reznik, Ketankumar Patel
Development of an Arginine Anchored Nanoglobule with Retrograde Trafficking Inhibitor (Retro-2) for the Treatment of an Enterohemorrhagic Escherichia coli Outbreak. Molecular pharmaceutics 16 (10) (2019)
Pranav Gupta, Hai-Ling Gao, Yunali V Ashar, Nishant M Karadkhelkar, Sabesan Yoganathan, Zhe-Sheng Chen
Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates. International journal of molecular sciences 20 (2) (2019)
Leonard Barasa, Sabesan Yoganathan
An efficient one-pot conversion of carboxylic acids into benzimidazoles via an HBTU-promoted methodology. RSC advances 8 (62) (2018)

Sabesan Yoganathan.css-eqlu8i{font-size:small;padding-left:4px;}